Universal ICU Decolonization
Without Antibiotics
1. Huang SS et al. Targeted versus universal. N Engl J Med, 2013: 368(24): 2255-65. Mupirocin and CHG used in study. 2. Huang SS et al. Cost Savings of Universal Decolonization
to Prevent Intensive Care Unit Infection. ICHE, 2014: 35 (S3): S23-S31. 3.
Steed L, et al. Reduction of nasal Staphylococcus aureus carriage. AJIC, 2014: 42(8): 841-846. ©2018 Global
Life Technologies Corp. All rights reserved. Made in USA. Nozin®, Nasal Sanitizer®, Leader in Nasal Decolonization™ are trademarks of Global Life Technologies Corp. Nozin® Nasal
Sanitizer® antiseptic is an OTC topical drug. No claim is made that it has an eect on any specic disease.
Savings estimates are for example only. Any actual savings may vary.
Compared to targeted screen and isolate, universal
nasal and skin decolonization of ICU patients has
shown superior outcomes.
1
Also, reducing screening
and contact isolation precautions can lower costs while
improving patient care.
2
Now you can have fast,
e•ective nasal decolonization without antibiotics.
• Safely Reduce MRSA Contact Precautions
• 30 Bed ICU Could Save $600k per Year
• Research Shows 44% HAI Reduction
1
• Improve Patient Care and Satisfaction
Alcohol-based Nozin® Nasal Sanitizer® antiseptic is
proven to decolonize nasal S. aureus day one.
3
Team up
with your Nozin advisor to assess the advantages of
this program. Learn how you can implement universal
ICU decolonization to help protect patients, relieve
sta• isolation fatigue and lower costs.
LEADER IN NASAL DECOLONIZATION
™
Evidence shows fewer infections
and lower costs with universal
nasal and skin decolonization.
1, 2
Nozin.com 877-669-4648
Ask a Nozin advisor for a custom savings
analysis and for professional samples.
ICU • MRSA CP
See Nozin at APIC 2018 Booth #1307
